Abstract
BackgroundDuration of disease has a considerable impact on the response to treatment with DMARDs in patients (pts) with RA. Those with longer disease duration do not respond as well to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
